GCG and type 2 diabetes mellitus: The results of the presented experiments herein may be of clinical interest especially in view of that FDA-approved GLP-1 analogues, such as exenatide and liraglutide, are approved for the treatment of diabetes type II and thus tentatively could be used as novel treatments of nicotine addiction.